OBJECTIVE: Mild obesity may have a protective effect against some diseases, termed an "obesity paradox." This study examined the effect of body mass index (Kg/m(2) BMI) on surgical 30-day morbidity and mortality in patients undergoing vascular surgical procedures. METHODS: As part of the National Surgical Quality Improvement Program (NSQIP), demographic and clinical risk variables, mortality, and 22 defined complications (morbidity) were obtained over three years from vascular services at 14 medical centers. At each medical center, patients from the operative schedule were prospectively and systematically enrolled according to NSQIP protocols. Outcomes and risk variables were compared across NIH-defined obesity classes (underweight [BMI<or=18.5], normal [18.5<BMI<25], overweight [25<BMI<or=30], obese I [30<BMI<or=35], obese II [35<BMI<or=40], and obese III [BMI>40]) using analysis of variance and means comparisons. Logistic regression was used to control for other risk factors. RESULTS: Vascular procedures in 7,543 patients included lower extremity revascularization (24.6%), aneurysm repair (17.4%), cerebrovascular procedures (17.3%), amputations (9.4%), and "other" procedures (31.3%). In the entire cohort, there were 1,659 (22.0%) patients with complications and 295 (3.9%) deaths. Risk factors of hypertension and diabetes increased with BMI (analysis of variance [ANOVA] P < .05) as expected; smoking, disseminated cancer, and stroke decreased (ANOVA P < .01). Twenty other risk factors, as well as mortality and morbidity, had "U" or "J"-shaped distributions with the highest incidence in underweight and/or obese class III extremes but reduced minimums in overweight or obese I classes (ANOVA P < .05). After controlling for age, gender, and operation type, mortality risk remained lowest in obese class I patients (Odds ratio [OR] 0.63, P = .023) while morbidity risk was highest in obese class III patients (OR 1.70, P = .0003), due to wound infection, thromboembolism, and renal complications. CONCLUSION: Underweight patients have poorer outcomes and class III obesity is associated with increased morbidity. Mildly obese patients have reduced co-morbid illness, surprisingly even less than normal-class patients, with correspondingly reduced mortality. Mild obesity is not a risk factor for 30-day outcomes after vascular surgery and confers an advantage.
OBJECTIVE: Mild obesity may have a protective effect against some diseases, termed an "obesity paradox." This study examined the effect of body mass index (Kg/m(2) BMI) on surgical 30-day morbidity and mortality in patients undergoing vascular surgical procedures. METHODS: As part of the National Surgical Quality Improvement Program (NSQIP), demographic and clinical risk variables, mortality, and 22 defined complications (morbidity) were obtained over three years from vascular services at 14 medical centers. At each medical center, patients from the operative schedule were prospectively and systematically enrolled according to NSQIP protocols. Outcomes and risk variables were compared across NIH-defined obesity classes (underweight [BMI<or=18.5], normal [18.5<BMI<25], overweight [25<BMI<or=30], obese I [30<BMI<or=35], obese II [35<BMI<or=40], and obese III [BMI>40]) using analysis of variance and means comparisons. Logistic regression was used to control for other risk factors. RESULTS: Vascular procedures in 7,543 patients included lower extremity revascularization (24.6%), aneurysm repair (17.4%), cerebrovascular procedures (17.3%), amputations (9.4%), and "other" procedures (31.3%). In the entire cohort, there were 1,659 (22.0%) patients with complications and 295 (3.9%) deaths. Risk factors of hypertension and diabetes increased with BMI (analysis of variance [ANOVA] P < .05) as expected; smoking, disseminated cancer, and stroke decreased (ANOVA P < .01). Twenty other risk factors, as well as mortality and morbidity, had "U" or "J"-shaped distributions with the highest incidence in underweight and/or obese class III extremes but reduced minimums in overweight or obese I classes (ANOVA P < .05). After controlling for age, gender, and operation type, mortality risk remained lowest in obese class Ipatients (Odds ratio [OR] 0.63, P = .023) while morbidity risk was highest in obese class III patients (OR 1.70, P = .0003), due to wound infection, thromboembolism, and renal complications. CONCLUSION: Underweight patients have poorer outcomes and class III obesity is associated with increased morbidity. Mildly obesepatients have reduced co-morbid illness, surprisingly even less than normal-class patients, with correspondingly reduced mortality. Mild obesity is not a risk factor for 30-day outcomes after vascular surgery and confers an advantage.
Authors: Amit K Mathur; Amir A Ghaferi; Nicholas H Osborne; Timothy M Pawlik; Darrell A Campbell; Michael J Englesbe; Theodore H Welling Journal: J Gastrointest Surg Date: 2010-06-08 Impact factor: 3.452
Authors: Ahmed Farhat; Areg Grigorian; Ninh T Nguyen; Brian Smith; Barbara J Williams; Sebastian D Schubl; Victor Joe; Dawn Elfenbein; Jeffry Nahmias Journal: Eur J Trauma Emerg Surg Date: 2019-05-20 Impact factor: 3.693
Authors: Katie E Shean; Sara L Zettervall; Sarah E Deery; Thomas F X O'Donnell; Peter A Soden; Joel M Johnson; Raul J Guzman; Marc L Schermerhorn Journal: Ann Vasc Surg Date: 2018-02-06 Impact factor: 1.466
Authors: Jason T Wiseman; Sara Fernandes-Taylor; Maggie L Barnes; R Scott Saunders; Sandeep Saha; Jeffrey Havlena; Paul J Rathouz; K Craig Kent Journal: J Vasc Surg Date: 2015-07-03 Impact factor: 4.268
Authors: Neel A Mansukhani; Katherine E Hekman; Dustin Y Yoon; Irene B Helenowski; Andrew W Hoel; Heron E Rodriguez; William H Pearce; Mark K Eskandari; Tadaki M Tomita Journal: Ann Vasc Surg Date: 2017-12-05 Impact factor: 1.466
Authors: Margriet Fokkema; Rodney P Bensley; Ruby C Lo; Allan D Hamden; Mark C Wyers; Frans L Moll; Gert Jan de Borst; Marc L Schermerhorn Journal: J Vasc Surg Date: 2013-02-04 Impact factor: 4.268
Authors: Marc G Jeschke; Celeste C Finnerty; Fatemeh Emdad; Haidy G Rivero; Robert Kraft; Felicia N Williams; Richard L Gamelli; Nicole S Gibran; Matthew B Klein; Brett D Arnoldo; Ronald G Tompkins; David N Herndon Journal: Ann Surg Date: 2013-12 Impact factor: 12.969